Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism

Linnea M. Baudhuin, W Edward Jr. Highsmith, Jennifer Skierka, Leonard Holtegaard, Brenda E. Moore, Dennis J. O'Kane

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objectives: The UGT1A1 promoter contains a (TA)n repeat polymorphism. The 7 repeat allele is associated with decreased enzyme activity and patients homozygous for this allele treated with irinotecan may experience life-threatening toxicity. Here, we have compared three methods [DNA sequencing, fragment analysis, and the Invader® assay (Third Wave Technologies)] for genotyping this polymorphism. Results: All of the DNA samples (n = 119) had concordant genotype calls between the sequencing and size-based methods. The Invader® method was also concordant if the genotypes were 6/6, 6/7, or 7/7. Both the size-based method and the Invader® method had straightforward data analysis, while interpretation of the sequencing results was occasionally more challenging. The Invader® method required more concentrated DNA for analysis, was more expensive, and had a limited genotyping spectrum. Conclusion: All three methods were valuable for genotyping the UGT1A1 (TA)n repeat, with the sequencing and size-based assays having the fewest drawbacks.

Original languageEnglish (US)
Pages (from-to)710-717
Number of pages8
JournalClinical Biochemistry
Volume40
Issue number9-10
DOIs
StatePublished - Jun 2007

Fingerprint

Polymorphism
irinotecan
Assays
DNA
Enzyme activity
Toxicity
Alleles
Genotype
Life Change Events
DNA Sequence Analysis
Technology
Enzymes

Keywords

  • Capillary electrophoresis
  • Fragment analysis
  • Genotyping
  • Irinotecan
  • Sequencing
  • TATA box
  • UGT1A1

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Baudhuin, L. M., Highsmith, W. E. J., Skierka, J., Holtegaard, L., Moore, B. E., & O'Kane, D. J. (2007). Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. Clinical Biochemistry, 40(9-10), 710-717. https://doi.org/10.1016/j.clinbiochem.2007.03.007

Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. / Baudhuin, Linnea M.; Highsmith, W Edward Jr.; Skierka, Jennifer; Holtegaard, Leonard; Moore, Brenda E.; O'Kane, Dennis J.

In: Clinical Biochemistry, Vol. 40, No. 9-10, 06.2007, p. 710-717.

Research output: Contribution to journalArticle

Baudhuin, LM, Highsmith, WEJ, Skierka, J, Holtegaard, L, Moore, BE & O'Kane, DJ 2007, 'Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism', Clinical Biochemistry, vol. 40, no. 9-10, pp. 710-717. https://doi.org/10.1016/j.clinbiochem.2007.03.007
Baudhuin LM, Highsmith WEJ, Skierka J, Holtegaard L, Moore BE, O'Kane DJ. Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. Clinical Biochemistry. 2007 Jun;40(9-10):710-717. https://doi.org/10.1016/j.clinbiochem.2007.03.007
Baudhuin, Linnea M. ; Highsmith, W Edward Jr. ; Skierka, Jennifer ; Holtegaard, Leonard ; Moore, Brenda E. ; O'Kane, Dennis J. / Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. In: Clinical Biochemistry. 2007 ; Vol. 40, No. 9-10. pp. 710-717.
@article{468826fd47ac4dba9116cb69b50625d8,
title = "Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism",
abstract = "Objectives: The UGT1A1 promoter contains a (TA)n repeat polymorphism. The 7 repeat allele is associated with decreased enzyme activity and patients homozygous for this allele treated with irinotecan may experience life-threatening toxicity. Here, we have compared three methods [DNA sequencing, fragment analysis, and the Invader{\circledR} assay (Third Wave Technologies)] for genotyping this polymorphism. Results: All of the DNA samples (n = 119) had concordant genotype calls between the sequencing and size-based methods. The Invader{\circledR} method was also concordant if the genotypes were 6/6, 6/7, or 7/7. Both the size-based method and the Invader{\circledR} method had straightforward data analysis, while interpretation of the sequencing results was occasionally more challenging. The Invader{\circledR} method required more concentrated DNA for analysis, was more expensive, and had a limited genotyping spectrum. Conclusion: All three methods were valuable for genotyping the UGT1A1 (TA)n repeat, with the sequencing and size-based assays having the fewest drawbacks.",
keywords = "Capillary electrophoresis, Fragment analysis, Genotyping, Irinotecan, Sequencing, TATA box, UGT1A1",
author = "Baudhuin, {Linnea M.} and Highsmith, {W Edward Jr.} and Jennifer Skierka and Leonard Holtegaard and Moore, {Brenda E.} and O'Kane, {Dennis J.}",
year = "2007",
month = "6",
doi = "10.1016/j.clinbiochem.2007.03.007",
language = "English (US)",
volume = "40",
pages = "710--717",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "9-10",

}

TY - JOUR

T1 - Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism

AU - Baudhuin, Linnea M.

AU - Highsmith, W Edward Jr.

AU - Skierka, Jennifer

AU - Holtegaard, Leonard

AU - Moore, Brenda E.

AU - O'Kane, Dennis J.

PY - 2007/6

Y1 - 2007/6

N2 - Objectives: The UGT1A1 promoter contains a (TA)n repeat polymorphism. The 7 repeat allele is associated with decreased enzyme activity and patients homozygous for this allele treated with irinotecan may experience life-threatening toxicity. Here, we have compared three methods [DNA sequencing, fragment analysis, and the Invader® assay (Third Wave Technologies)] for genotyping this polymorphism. Results: All of the DNA samples (n = 119) had concordant genotype calls between the sequencing and size-based methods. The Invader® method was also concordant if the genotypes were 6/6, 6/7, or 7/7. Both the size-based method and the Invader® method had straightforward data analysis, while interpretation of the sequencing results was occasionally more challenging. The Invader® method required more concentrated DNA for analysis, was more expensive, and had a limited genotyping spectrum. Conclusion: All three methods were valuable for genotyping the UGT1A1 (TA)n repeat, with the sequencing and size-based assays having the fewest drawbacks.

AB - Objectives: The UGT1A1 promoter contains a (TA)n repeat polymorphism. The 7 repeat allele is associated with decreased enzyme activity and patients homozygous for this allele treated with irinotecan may experience life-threatening toxicity. Here, we have compared three methods [DNA sequencing, fragment analysis, and the Invader® assay (Third Wave Technologies)] for genotyping this polymorphism. Results: All of the DNA samples (n = 119) had concordant genotype calls between the sequencing and size-based methods. The Invader® method was also concordant if the genotypes were 6/6, 6/7, or 7/7. Both the size-based method and the Invader® method had straightforward data analysis, while interpretation of the sequencing results was occasionally more challenging. The Invader® method required more concentrated DNA for analysis, was more expensive, and had a limited genotyping spectrum. Conclusion: All three methods were valuable for genotyping the UGT1A1 (TA)n repeat, with the sequencing and size-based assays having the fewest drawbacks.

KW - Capillary electrophoresis

KW - Fragment analysis

KW - Genotyping

KW - Irinotecan

KW - Sequencing

KW - TATA box

KW - UGT1A1

UR - http://www.scopus.com/inward/record.url?scp=34249727317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249727317&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2007.03.007

DO - 10.1016/j.clinbiochem.2007.03.007

M3 - Article

VL - 40

SP - 710

EP - 717

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 9-10

ER -